查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
奈米颗粒药物传输系统的全球市场（2024-2028）
市场调查报告书
商品编码
1581181

奈米颗粒药物传输系统的全球市场（2024-2028）

Global Nanoparticle Drug Delivery Systems Market 2024-2028
出版日期: | 出版商: TechNavio | 英文 198 Pages | 订单完成后即时交付

价格

奈米颗粒给药系统市场（2024-2028）

奈米颗粒药物输送系统市场预计从 2023 年到 2028 年将扩大 549 亿美元，预测期内复合年增长率为 10%。该报告包括对奈米颗粒药物输送系统市场的总体分析、市场规模/预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。

该报告提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的推动因素包括慢性病的流行、全球老年人口的增加以及政府对奈米技术研究和开发的支持力度的加强。

市场范围
基准年 2024年
结束年份 2028年
预测期 2024-2028
成长动力 加速度
与前一年同期比较（2024 年） 9.6%
复合年增长率 10%
增量 549亿美元

该报告指出，奈米医学领域不断增长的技术创新是未来几年推动奈米颗粒药物传输系统市场成长的关键原因之一。此外，奈米医学在药物传输中的重要性日益增加以及对个人化医疗的日益偏好将导致巨大的市场需求。

目录

第一章执行摘要

  • 市场概况

第二章 Technavio 分析

  • 价格敏感度、生命週期、顾客购买篮子、采用率和购买标准分析
  • 输入和差异化因素的重要性
  • 令人困惑的因素
  • 驱动因素和挑战的影响

第三章 市场状况

  • 市场生态系统
  • 市场特征
  • 价值链分析

第四章市场规模评估

  • 市场定义
  • 细分市场分析
  • 市场规模（2023年）
  • 市场展望（2023-2028）

第五章 市场规模表现

  • 奈米颗粒药物传输系统的全球市场（2018-2022）
  • 依给药途径分析（2018-2022）
  • 最终用户分析（2018-2022）
  • 区域分析（2018-2022）
  • 国家分析（2018-2022）

第6章定性分析

  • 全球奈米颗粒药物传输系统市场的人工智慧内容

第7章五力分析

  • 五力摘要
  • 买方议价能力
  • 供应商的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争威胁
  • 市场状况

第八章 市场区隔：依管理途径

  • 市场区隔
  • 比较：按给药途径
  • 静脉注射：市场规模与预测（2023-2028）
  • 口头：市场规模及预测（2023-2028）
  • 局部：市场规模与预测（2023-2028）
  • 按管理途径的市场机会

第 9 章 市场区隔：依最终用户

  • 市场区隔
  • 比较：按最终用户
  • 医院/诊所：市场规模与预测（2023-2028）
  • 製药公司：市场规模及预测（2023-2028）
  • 研究院：市场规模及预测（2023-2028）
  • 最终用户的市场机会

第十章 客户情况

  • 客户状况概览

第十一章 地区情势

  • 区域细分
  • 区域比较
  • 北美：市场规模与预测（2023-2028）
  • 欧洲：市场规模与预测（2023-2028）
  • 亚洲：市场规模与预测（2023-2028）
  • 世界其他地区：市场规模与预测（2023-2028）
  • 美国：市场规模与预测（2023-2028）
  • 德国：市场规模与预测（2023-2028）
  • 英国：市场规模与预测（2023-2028）
  • 中国：市场规模及预测（2023-2028）
  • 日本：市场规模与预测（2023-2028）
  • 法国：市场规模与预测（2023-2028）
  • 西班牙：市场规模与预测（2023-2028）
  • 加拿大：市场规模与预测（2023-2028）
  • 韩国：市场规模与预测（2023-2028）
  • 巴西：市场规模与预测（2023-2028）
  • 按地区分類的市场机会

第十二章 促进因素、挑战、机会与限制因素

  • 市场驱动因素
  • 市场挑战
  • 驱动因素和挑战的影响
  • 市场机会与限制

第十三章竞争格局

  • 概述
  • 竞争格局
  • 混乱的情况
  • 产业风险

第14章竞争分析

  • 公司简介
  • 公司排名指数
  • 公司市场定位
  • Alnylam Pharmaceuticals Inc.
  • CD Bioparticles
  • CSPC Pharmaceutical Group Ltd.
  • Izon Science Ltd.
  • Jazz Pharmaceuticals Plc
  • Luye Pharma Group Ltd.
  • Nano Daru Pharmaceutical Co
  • Nanoform Finland Oyj
  • NanoMedical Systems, Inc
  • Nanovex Biotechnologies SL
  • Precision NanoSystems Inc
  • Sayre Therapeutics Pvt Ltd
  • Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd
  • Sun Pharmaceutical Industries Ltd.

第十五章附录

Product Code: IRTNTR80209

Nanoparticle Drug Delivery Systems Market 2024-2028

The nanoparticle drug delivery systems market is forecasted to grow by USD 54.90 bn during 2023-2028, accelerating at a CAGR of 10% during the forecast period. The report on the nanoparticle drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, increasing global geriatric population, and increasing government support for research and development in nanotechnology.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20249.6%
CAGR10%
Incremental Value$54.90 bn

Technavio's nanoparticle drug delivery systems market is segmented as below:

By Route Of Administration

    • Intravenous
    • Oral
    • Topical

By End-user

    • Hospitals and clinics
    • Pharmaceutical companies
    • Research institutions

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the growing innovations in nanomedicine as one of the prime reasons driving the market growth of nanoparticle drug delivery systems during the next few years. Also, the growing significance of nanomedicine in drug delivery and increasing preference for personalized medicine will lead to sizable demand in the market.

The report on the nanoparticle drug delivery systems market covers the following areas:

    • Nanoparticle Drug Delivery Systems Market sizing
    • Nanoparticle Drug Delivery Systems Market forecast
    • Nanoparticle Drug Delivery Systems Market industry analysis

The robust vendor analysis is designed to help clients improve their market position. In line with this, this report provides a detailed analysis of several leading nanoparticle drug delivery systems market vendors that include Alnylam Pharmaceuticals Inc., Aquestive Therapeutics Inc, CD Bioparticles, CSPC Pharmaceutical Group Ltd., Izon Science Ltd., Jazz Pharmaceuticals PLC, Luye Pharma Group Ltd., Nano Daru Pharmaceutical Co, Nanoform Finland Oyj, NanoMedical Systems, Inc, Nanovex Biotechnologies SL, Precision NanoSystems Inc, Sayre Therapeutics Pvt Ltd, Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd, and Sun Pharmaceutical Industries Ltd. Also, the nanoparticle drug delivery systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Nanoparticle Drug Delivery Systems Market 2018 - 2022
    • Historic Market Size - Data Table on Global Nanoparticle Drug Delivery Systems Market 2018 - 2022 ($ billion)
  • 5.2 Route of Administration segment analysis 2018 - 2022
    • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
  • 5.3 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
  • 5.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 5.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

6 Qualitative Analysis

  • 6.1 AI content for global nanoparticle drug delivery systems market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Route of Administration

  • 8.1 Market segments
    • Chart on Route of Administration - Market share 2023-2028 (%)
    • Data Table on Route of Administration - Market share 2023-2028 (%)
  • 8.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 8.3 Intravenous - Market size and forecast 2023-2028
    • Chart on Intravenous - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Intravenous - Market size and forecast 2023-2028 ($ billion)
    • Chart on Intravenous - Year-over-year growth 2023-2028 (%)
    • Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
  • 8.4 Oral - Market size and forecast 2023-2028
    • Chart on Oral - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
    • Chart on Oral - Year-over-year growth 2023-2028 (%)
    • Data Table on Oral - Year-over-year growth 2023-2028 (%)
  • 8.5 Topical - Market size and forecast 2023-2028
    • Chart on Topical - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Topical - Market size and forecast 2023-2028 ($ billion)
    • Chart on Topical - Year-over-year growth 2023-2028 (%)
    • Data Table on Topical - Year-over-year growth 2023-2028 (%)
  • 8.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ billion)
    • Data Table on Market opportunity by Route of Administration ($ billion)

9 Market Segmentation by End-user

  • 9.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 9.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 9.3 Hospitals and clinics - Market size and forecast 2023-2028
    • Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
    • Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • 9.4 Pharmaceutical companies - Market size and forecast 2023-2028
    • Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
    • Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • 9.5 Research institutions - Market size and forecast 2023-2028
    • Chart on Research institutions - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Research institutions - Market size and forecast 2023-2028 ($ billion)
    • Chart on Research institutions - Year-over-year growth 2023-2028 (%)
    • Data Table on Research institutions - Year-over-year growth 2023-2028 (%)
  • 9.6 Market opportunity by End-user
    • Market opportunity by End-user ($ billion)
    • Data Table on Market opportunity by End-user ($ billion)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 11.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 11.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 11.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 11.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 11.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 11.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 11.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 11.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 11.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 11.12 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ billion)
    • Data Table on France - Market size and forecast 2023-2028 ($ billion)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 11.13 Spain - Market size and forecast 2023-2028
    • Chart on Spain - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Spain - Market size and forecast 2023-2028 ($ billion)
    • Chart on Spain - Year-over-year growth 2023-2028 (%)
    • Data Table on Spain - Year-over-year growth 2023-2028 (%)
  • 11.14 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 11.15 South Korea - Market size and forecast 2023-2028
    • Chart on South Korea - Market size and forecast 2023-2028 ($ billion)
    • Data Table on South Korea - Market size and forecast 2023-2028 ($ billion)
    • Chart on South Korea - Year-over-year growth 2023-2028 (%)
    • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • 11.16 Brazil - Market size and forecast 2023-2028
    • Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Chart on Brazil - Year-over-year growth 2023-2028 (%)
    • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • 11.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

12 Drivers, Challenges, and Opportunity/Restraints

  • 12.1 Market drivers
  • 12.2 Market challenges
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 12.4 Market opportunities/restraints

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Company ranking index
    • Company ranking index
  • 14.3 Market positioning of companies
    • Matrix on companies position and classification
  • 14.4 Alnylam Pharmaceuticals Inc.
    • Alnylam Pharmaceuticals Inc. - Overview
    • Alnylam Pharmaceuticals Inc. - Product / Service
    • Alnylam Pharmaceuticals Inc. - Key offerings
    • SWOT
  • 14.5 CD Bioparticles
    • CD Bioparticles - Overview
    • CD Bioparticles - Product / Service
    • CD Bioparticles - Key offerings
    • SWOT
  • 14.6 CSPC Pharmaceutical Group Ltd.
    • CSPC Pharmaceutical Group Ltd. - Overview
    • CSPC Pharmaceutical Group Ltd. - Business segments
    • CSPC Pharmaceutical Group Ltd. - Key offerings
    • CSPC Pharmaceutical Group Ltd. - Segment focus
    • SWOT
  • 14.7 Izon Science Ltd.
    • Izon Science Ltd. - Overview
    • Izon Science Ltd. - Product / Service
    • Izon Science Ltd. - Key offerings
    • SWOT
  • 14.8 Jazz Pharmaceuticals Plc
    • Jazz Pharmaceuticals Plc - Overview
    • Jazz Pharmaceuticals Plc - Product / Service
    • Jazz Pharmaceuticals Plc - Key news
    • Jazz Pharmaceuticals Plc - Key offerings
    • SWOT
  • 14.9 Luye Pharma Group Ltd.
    • Luye Pharma Group Ltd. - Overview
    • Luye Pharma Group Ltd. - Business segments
    • Luye Pharma Group Ltd. - Key offerings
    • Luye Pharma Group Ltd. - Segment focus
    • SWOT
  • 14.10 Nano Daru Pharmaceutical Co
    • Nano Daru Pharmaceutical Co - Overview
    • Nano Daru Pharmaceutical Co - Product / Service
    • Nano Daru Pharmaceutical Co - Key offerings
    • SWOT
  • 14.11 Nanoform Finland Oyj
    • Nanoform Finland Oyj - Overview
    • Nanoform Finland Oyj - Product / Service
    • Nanoform Finland Oyj - Key offerings
    • SWOT
  • 14.12 NanoMedical Systems, Inc
    • NanoMedical Systems, Inc - Overview
    • NanoMedical Systems, Inc - Product / Service
    • NanoMedical Systems, Inc - Key offerings
    • SWOT
  • 14.13 Nanovex Biotechnologies SL
    • Nanovex Biotechnologies SL - Overview
    • Nanovex Biotechnologies SL - Product / Service
    • Nanovex Biotechnologies SL - Key offerings
    • SWOT
  • 14.14 Precision NanoSystems Inc
    • Precision NanoSystems Inc - Overview
    • Precision NanoSystems Inc - Product / Service
    • Precision NanoSystems Inc - Key offerings
    • SWOT
  • 14.15 Sayre Therapeutics Pvt Ltd
    • Sayre Therapeutics Pvt Ltd - Overview
    • Sayre Therapeutics Pvt Ltd - Product / Service
    • Sayre Therapeutics Pvt Ltd - Key offerings
    • SWOT
  • 14.16 Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd
    • Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd - Overview
    • Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd - Product / Service
    • Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd - Key offerings
    • SWOT
  • 14.17 Sun Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd. - Overview
    • Sun Pharmaceutical Industries Ltd. - Product / Service
    • Sun Pharmaceutical Industries Ltd. - Key news
    • Sun Pharmaceutical Industries Ltd. - Key offerings
    • SWOT

15 Appendix

  • 15.1 Scope of the report
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits11: Overview on criticality of inputs and factors of differentiation
  • Exhibits12: Overview on factors of disruption
  • Exhibits13: Impact of drivers and challenges in 2023 and 2028
  • Exhibits14: Parent Market
  • Exhibits15: Data Table on - Parent Market
  • Exhibits16: Market characteristics analysis
  • Exhibits17: Value Chain Analysis
  • Exhibits18: Offerings of companies included in the market definition
  • Exhibits19: Market segments
  • Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits24: Historic Market Size - Data Table on Global Nanoparticle Drug Delivery Systems Market 2018 - 2022 ($ billion)
  • Exhibits25: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
  • Exhibits26: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
  • Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits29: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits35: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits36: Chart on Route of Administration - Market share 2023-2028 (%)
  • Exhibits37: Data Table on Route of Administration - Market share 2023-2028 (%)
  • Exhibits38: Chart on Comparison by Route of Administration
  • Exhibits39: Data Table on Comparison by Route of Administration
  • Exhibits40: Chart on Intravenous - Market size and forecast 2023-2028 ($ billion)
  • Exhibits41: Data Table on Intravenous - Market size and forecast 2023-2028 ($ billion)
  • Exhibits42: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
  • Exhibits45: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
  • Exhibits46: Chart on Oral - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Oral - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Topical - Market size and forecast 2023-2028 ($ billion)
  • Exhibits49: Data Table on Topical - Market size and forecast 2023-2028 ($ billion)
  • Exhibits50: Chart on Topical - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Topical - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Market opportunity by Route of Administration ($ billion)
  • Exhibits53: Data Table on Market opportunity by Route of Administration ($ billion)
  • Exhibits54: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits55: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits56: Chart on Comparison by End-user
  • Exhibits57: Data Table on Comparison by End-user
  • Exhibits58: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits59: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits60: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Exhibits63: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Exhibits64: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Chart on Research institutions - Market size and forecast 2023-2028 ($ billion)
  • Exhibits67: Data Table on Research institutions - Market size and forecast 2023-2028 ($ billion)
  • Exhibits68: Chart on Research institutions - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Research institutions - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Market opportunity by End-user ($ billion)
  • Exhibits71: Data Table on Market opportunity by End-user ($ billion)
  • Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits75: Chart on Geographic comparison
  • Exhibits76: Data Table on Geographic comparison
  • Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits110: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits111: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits114: Data Table on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits115: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Chart on Spain - Market size and forecast 2023-2028 ($ billion)
  • Exhibits118: Data Table on Spain - Market size and forecast 2023-2028 ($ billion)
  • Exhibits119: Chart on Spain - Year-over-year growth 2023-2028 (%)
  • Exhibits120: Data Table on Spain - Year-over-year growth 2023-2028 (%)
  • Exhibits121: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits122: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits123: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits124: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits125: Chart on South Korea - Market size and forecast 2023-2028 ($ billion)
  • Exhibits126: Data Table on South Korea - Market size and forecast 2023-2028 ($ billion)
  • Exhibits127: Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits128: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits129: Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Exhibits130: Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Exhibits131: Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits132: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits133: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits135: Impact of drivers and challenges in 2023 and 2028
  • Exhibits136: Overview on criticality of inputs and factors of differentiation
  • Exhibits137: Overview on factors of disruption
  • Exhibits138: Impact of key risks on business
  • Exhibits139: Companies covered
  • Exhibits140: Company ranking index
  • Exhibits141: Matrix on companies position and classification
  • Exhibits142: Alnylam Pharmaceuticals Inc. - Overview
  • Exhibits143: Alnylam Pharmaceuticals Inc. - Product / Service
  • Exhibits144: Alnylam Pharmaceuticals Inc. - Key offerings
  • Exhibits145: SWOT
  • Exhibits146: CD Bioparticles - Overview
  • Exhibits147: CD Bioparticles - Product / Service
  • Exhibits148: CD Bioparticles - Key offerings
  • Exhibits149: SWOT
  • Exhibits150: CSPC Pharmaceutical Group Ltd. - Overview
  • Exhibits151: CSPC Pharmaceutical Group Ltd. - Business segments
  • Exhibits152: CSPC Pharmaceutical Group Ltd. - Key offerings
  • Exhibits153: CSPC Pharmaceutical Group Ltd. - Segment focus
  • Exhibits154: SWOT
  • Exhibits155: Izon Science Ltd. - Overview
  • Exhibits156: Izon Science Ltd. - Product / Service
  • Exhibits157: Izon Science Ltd. - Key offerings
  • Exhibits158: SWOT
  • Exhibits159: Jazz Pharmaceuticals Plc - Overview
  • Exhibits160: Jazz Pharmaceuticals Plc - Product / Service
  • Exhibits161: Jazz Pharmaceuticals Plc - Key news
  • Exhibits162: Jazz Pharmaceuticals Plc - Key offerings
  • Exhibits163: SWOT
  • Exhibits164: Luye Pharma Group Ltd. - Overview
  • Exhibits165: Luye Pharma Group Ltd. - Business segments
  • Exhibits166: Luye Pharma Group Ltd. - Key offerings
  • Exhibits167: Luye Pharma Group Ltd. - Segment focus
  • Exhibits168: SWOT
  • Exhibits169: Nano Daru Pharmaceutical Co - Overview
  • Exhibits170: Nano Daru Pharmaceutical Co - Product / Service
  • Exhibits171: Nano Daru Pharmaceutical Co - Key offerings
  • Exhibits172: SWOT
  • Exhibits173: Nanoform Finland Oyj - Overview
  • Exhibits174: Nanoform Finland Oyj - Product / Service
  • Exhibits175: Nanoform Finland Oyj - Key offerings
  • Exhibits176: SWOT
  • Exhibits177: NanoMedical Systems, Inc - Overview
  • Exhibits178: NanoMedical Systems, Inc - Product / Service
  • Exhibits179: NanoMedical Systems, Inc - Key offerings
  • Exhibits180: SWOT
  • Exhibits181: Nanovex Biotechnologies SL - Overview
  • Exhibits182: Nanovex Biotechnologies SL - Product / Service
  • Exhibits183: Nanovex Biotechnologies SL - Key offerings
  • Exhibits184: SWOT
  • Exhibits185: Precision NanoSystems Inc - Overview
  • Exhibits186: Precision NanoSystems Inc - Product / Service
  • Exhibits187: Precision NanoSystems Inc - Key offerings
  • Exhibits188: SWOT
  • Exhibits189: Sayre Therapeutics Pvt Ltd - Overview
  • Exhibits190: Sayre Therapeutics Pvt Ltd - Product / Service
  • Exhibits191: Sayre Therapeutics Pvt Ltd - Key offerings
  • Exhibits192: SWOT
  • Exhibits193: Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd - Overview
  • Exhibits194: Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd - Product / Service
  • Exhibits195: Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd - Key offerings
  • Exhibits196: SWOT
  • Exhibits197: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits198: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits199: Sun Pharmaceutical Industries Ltd. - Key news
  • Exhibits200: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits201: SWOT
  • Exhibits202: Inclusions checklist
  • Exhibits203: Exclusions checklist
  • Exhibits204: Currency conversion rates for US$
  • Exhibits205: Research methodology
  • Exhibits206: Information sources
  • Exhibits207: Data validation
  • Exhibits208: Validation techniques employed for market sizing
  • Exhibits209: Data synthesis
  • Exhibits210: 360 degree market analysis
  • Exhibits211: List of abbreviations